Key statistics
On Friday, AxoGen Inc (LT3:STU) closed at 29.40, -2.65% below its 52-week high of 30.20, set on Feb 03, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 28.40 |
|---|---|
| High | 30.00 |
| Low | 28.20 |
| Bid | 29.40 |
| Offer | 29.60 |
| Previous close | 28.60 |
| Average volume | 96.40 |
|---|---|
| Shares outstanding | 50.12m |
| Free float | 48.83m |
| P/E (TTM) | -- |
| Market cap | 1.70bn USD |
| EPS (TTM) | -0.0486 USD |
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Announcements
- Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock
- Axogen Announces Proposed Public Offering of Common Stock
- Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025
- Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference
- Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx)
- Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
- Axogen, Inc. Reports Third Quarter 2025 Financial Results
- Axogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025
- Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
- Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft
More ▼
